PRAT increase induces dysfunction of adipokine secretion and local chronic inflammation, modulating most of the obesity-related tumors through paracrine or endocrine pathways [2,16,17]. This evidence concerns the gene PPAT and obesity due to melanocortin 4 receptor deficiency.